Cart
sales@molnova.com
Anle138b
CAS No. 882697-00-9
Anle138b( —— )
Catalog No. M20225 CAS No. 882697-00-9
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 30 | In Stock |
|
| 5MG | 47 | In Stock |
|
| 10MG | 80 | In Stock |
|
| 25MG | 174 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 386 | In Stock |
|
| 200MG | 556 | In Stock |
|
| 500MG | 869 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAnle138b
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease.
-
DescriptionAnle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease.
-
In Vitro——
-
In VivoAnimal Model:Two‐month‐old PLP‐hαSyn miceDosage:0.6 and 2 g/kg Administration:Oral Result:Prevented motor deficits and neurodegeneration in the PLP‐hαSyn mice.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number882697-00-9
-
Formula Weight343.17
-
Molecular FormulaC16H11BrN2O2?
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL?(145.70 mM)
-
SMILESC1OC2=C(O1)C=C(C=C2)C3=CC(=NN3)C4=CC(=CC=C4)Br
-
Chemical Name5-(13-Benzodioxol-5-yl)-3-(3-bromophenyl)-1H-pyrazole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wagner J et al. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. Acta Neuropathol. 2013 Jun;125(6):795-813.
molnova catalog
related products
-
2-(Pyridyldithio)eth...
2-(Pyridyldithio)ethylamine hydrochloride is a disulfide intercalating cross-linking reagent.
-
Carbocisteine
Carbocysteine is a compound formed when the iodoacetic acid reacts with sulfhydryl groups in proteins. It has been used as an anti-infective nasal spray with mucolytic and expectorant action.
-
Sotatercept
Sotatercept (ACE-011) is an activin receptor type IIA-Fc (ActRIIA-Fc) fusion protein and inhibitor of activin signaling.Sotatercept can be used in the study of pulmonary arterial hypertension.
